SCHEMBL4488488

SCHEMBL4488488

O=C(O)CNc1nc2cc3nc(NCC(=O)O)sc3cc2s1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.50
PTGS2 P35354 2/20 0.48
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
POLB P06746 2/20 0.41
MITF O75030 1/20 0.41
APEX1 P27695 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
HSD17B10 Q99714 1/20 0.40
MAPT P10636 1/20 0.39
MGLL Q99685 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PCSK9 Q8NBP7 1/20 0.39
DYRK1A Q13627 4/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9963605 0.90 PTGS2 (0.45) HDAC6PTGS2NPC1RAB9AMAPT
SCHEMBL9928638 0.86 ALDH1A1 (0.48) HDAC6PTGS2NPC1RAB9APOLB
SCHEMBL9963610 0.84 PTGS2 (0.54) HDAC6PTGS2NPC1RAB9AHSD17B10
SCHEMBL9963506 0.83 HDAC6 (0.55) HDAC6NPC1RAB9APOLBMITF
SCHEMBL9963498 0.82 TOP2A (0.46) NPC1RAB9AMAPTSMN1; SMN2DYRK1A
SCHEMBL8977465 0.82 NPC1 (0.54) PTGS2NPC1RAB9APOLBMITF
SCHEMBL27839973 0.82 DYRK1A (0.63) NPC1RAB9APOLBMITFAPEX1
SCHEMBL6640386 0.80 POLB (0.62) PTGS2NPC1RAB9APOLBMAPT
SCHEMBL9963602 0.79 PTGS2 (0.44) PTGS2NPC1RAB9APOLBMITF
SCHEMBL9963516 0.79 PTGS2 (0.44) HDAC6PTGS2NPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US claimed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US claimed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258857-A1 CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 HDAC6 2280/4885PTGS2 2872/4885NPC1 93/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.